The cell proliferation stimulated by ovarian steroids may be an important determinant of cancer risk in hormonally responsive tissues, since there is an increased risk of genetic errors occurring during the process of cell division. DNA labeling index (DNA LI) was determined in mammary glands of female 35-day old (n=9) and adult cycling (3 to 8 months old, n=29) CD-1 mice, and was contrasted with the uterine lumenal and glandular epithelium labeling pattern in each animal. Vaginal smears were obtained to determine stage and regularity of the estrous cycle. Animals were injected (i.p.) with 5-bromo 2'-deoxyuridine (BrDU) at 50 mg/kg to label nuclei in S-phase, and 2 hours later the fourth mammary gland, a mid-section of the uterine horn and a piece of the duodenum were removed, fixed in ice-cold 4% paraformaldehyde overnight, dehydrated, embedded in paraffin and sectioned. Labeled nuclei were detected immunohistochemically with a rat anti-BrDU monoclonal antibody using the avidin biotin peroxidase method. DNA LI was expressed as the percent of labeled epithelial nuclei. Despite a variable pattern in the labeling of uterine epithelium in the 35-day old animals, all mammary glands examined displayed extensive labeling in the terminal end buds (TEBs) (Mean plus/minus SEM, 13.1 plus/minus 0.7). Ductal labeling was comparatively low (1.3 plus/minus 0.5) and did not appear to be related to the pattern of uterine epithelial labeling in these sub-adult mice. In contrast, mammary ductal labeling in adult animals was negatively correlated with the combined uterine lumenal and glandular epithelial DNA LI (p less that 0.05, r= -0.426). Animals (n=7) with the highest uterine DNA LI (40.2 to 70.8) had low mammary ductal DNA LI (less than 1.0), while the 4 animals with the highest mammary ductal DNA LI (4.4. to 10.9) had a uterine DNA LI of less than 0.5. Several animals with high mammary labeling had thin uteri, and were at the end of estrus or in metestrus. The inversely correlated patterns of epithelial DNA Li in uterus and mammary gland supports the concept that in adult animals the hormonal requirement for proliferation in the mammary gland is different from that of the uterus.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES048005-05
Application #
3841088
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Schmitt, M; Walker, M P; Richards, R G et al. (2006) Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors. Mol Carcinog 45:490-505
Fukuda, Tomokazu; Mishina, Yuji; Walker, Michael P et al. (2005) Conditional transgenic system for mouse aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein. Mol Cell Biol 25:5270-81
Richards, R Gregg; Klotz, Diane M; Walker, Michael P et al. (2004) Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I. Endocrinology 145:3106-10
Baek, Seung Joon; Kim, Jong-Sik; Nixon, Jennifer B et al. (2004) Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 279:6883-92
Burroughs, Kevin D; Oh, Jennifer; Barrett, J Carl et al. (2003) Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1? Mol Cancer Res 1:312-22
Richards, R G; Klotz, D M; Bush, M R et al. (2001) E2-induced degradation of uterine insulin receptor substrate-2: requirement for an IGF-I-stimulated, proteasome-dependent pathway. Endocrinology 142:3842-9
Newbold, R R; DiAugustine, R P; Risinger, J I et al. (2000) Advances in uterine leiomyoma research: conference overview, summary, and future research recommendations. Environ Health Perspect 108 Suppl 5:769-73